January 9, 2026 · Form 4 insider transaction
FRIEDMAN PAUL A sold 40 shares of Madrigal Pharmaceuticals, Inc. at $545.79 per share, a transaction worth $21.8K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.